SBFMW Sunshine Biopharma Inc. - Warrant
$0,09
Fiyat · Haz 24, 2026
Temel veriler itibarıyla Nis 3, 2026
52 Haftlık Aralık
$0–$0
0% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
—
ROE
-24.5%
Net Kâr Marjı
-16.5%
SBFMW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.09
Piyasa Değeri
$966.5K
P/E (TTM)
—
EPS (TTM)
$-7.32
Gelir (TTM)
$36M
Temettü Verimi
—
ROE
-24.5%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
SBFMW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$36M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-7.32
2021-12-31
→
2024-12-31
Serbest Nakit Akışı
$-6M
2016-12-31
→
2025-12-31
Marjlar
-16.5%
2018-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
SBFMW
Akran Ortalaması
P/S (TTM) (F/S (TTM))
0.0
—
P/B (F/D)
0.0
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-0.2
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
SBFMW
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
33.8%
—
Operating Margin (Faaliyet Kâr Marjı)
-17.2%
—
Net Profit Margin (Net Kâr Marjı)
-16.5%
—
ROA
-19.7%
—
ROE
-24.5%
—
ROIC
-27.1%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
SBFMW
Akran Ortalaması
Current Ratio (Cari Oran)
4.2
—
Quick Ratio (Cari Oran)
0.5
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
SBFMW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
4.1%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
102.9%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
247.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
SBFMW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36M | $35M | $24M | $4M | $228.4K | $71.4K | $21.1K | $0 | $0 | $0 | $1.7K | $0 | |
| Cost of Revenue | $24M | $24M | $16M | $3M | $117.8K | $25.8K | $11.1K | $0 | $0 | · | · | · | |
| Gross Profit | $12M | $11M | $8M | $2M | $110.6K | $45.6K | $10.1K | $0 | $0 | · | · | · | |
| R&D Expense | $604.3K | $933.9K | $2M | $811.9K | $672.2K | $1.7K | $15.2K | $12.8K | $0 | $32.8K | $8.7K | $327.0K | |
| SG&A Expense | $18M | $16M | $13M | $29M | $3M | $622.4K | $651.7K | $1M | $857.2K | $993.1K | $782.0K | $2M | |
| Operating Income | $-6M | $-6M | $-5M | $-27M | $-2M | $-576.9K | $-641.6K | $-1M | $-857.2K | $-993.1K | $-780.3K | $-2M | |
| Interest Expense | · | · | $137.3K | $39.4K | $328.8K | $168.1K | $115.9K | $143.5K | $104.8K | $34.7K | $307.2K | $140.9K | |
| Other Non-op | $273.3K | $443.1K | $674.4K | $489.6K | $-10M | $-2M | $-436.4K | $-973.7K | $-183.0K | $-3M | $-872.6K | $-179.1K | |
| Pretax Income | $-6M | $-5M | $-4M | $-27M | $-12M | · | · | · | · | · | · | · | |
| Income Tax | $21.6K | $-234.9K | $395.2K | $233.3K | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-6M | $-5M | $-5M | $-27M | $-12M | $-3M | $-2M | $-2M | $-1M | $-3M | $-2M | $-2M | |
| EPS (Basic) | $-1.44 | $-7.32 | $-351.36 | $-1.76 | $-4.76 | $-2.73 | $-0.15 | $-0.71 | $-0.02 | $-0.01 | $-0.01 | $-0.03 | |
| EPS (Diluted) | · | $-7.32 | $-351.36 | $-1.76 | $-4.76 | · | · | · | · | · | · | · | |
| Shares (Basic) | 4,157,086 | 701,749 | 12,825 | 15,180,868 | 2,612,061 | 1,020,482 | 10,932,813 | 3,046,807 | 43,634,280 | 424,874,458 | 122,278,909 | 66,131,657 | |
| Shares (Diluted) | · | 701,749 | 12,825 | 15,180,868 | 2,612,061 | · | · | · | · | · | · | · | |
| EBITDA | $-6M | $-6M | $-5M | $-27M | $-2M | $-576.9K | $-641.6K | $-1M | $-857.2K | $-993.1K | $-780.3K | $-2M |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $22M | $2M | $989.9K | $40.5K | $110.5K | $107.5K | $57.5K | $50.8K | $143.4K | |
| Receivables | $3M | $4M | $3M | $2M | $7.8K | $1.9K | $430 | $0 | $0 | · | $3.1K | $0 | |
| Inventory | $13M | $11M | $6M | $3M | $105.7K | $23.8K | $15.9K | $0 | · | · | · | · | |
| Prepaid Expense | $798.4K | $1M | $310.6K | $283.8K | $29.6K | $2.8K | $1.3K | $1.3K | $9.7K | $1.0K | $3.1K | $0 | |
| Current Assets | $27M | $26M | $25M | $27M | $2M | $1M | $65.7K | $1M | $117.2K | $58.5K | $53.9K | $143.4K | |
| PP&E (Net) | $557.4K | $546.1K | $365.9K | $394.2K | $7.1K | $19.5K | $32.5K | $45.1K | $60.0K | $5.9K | $4.3K | $0 | |
| PP&E (Gross) | $1M | $882.6K | $555.9K | $478.1K | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $512.9K | $336.5K | $190.0K | $83.8K | $64.1K | $51.5K | $37.1K | $23.0K | $9.1K | $2.3K | $479 | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | · | $665.7K | $665.7K | $0 | · | · | · | |
| Intangibles | $2M | $3M | $1M | $776.9K | $0 | $0 | $0 | $0 | $0 | $0 | $615.0K | $0 | |
| Total Assets | $30M | $31M | $27M | $29M | $2M | $1M | $98.1K | $1M | $257.5K | $64.4K | $673.3K | $143.4K | |
| Accounts Payable | $6M | $6M | $3M | $3M | $42.9K | $62.9K | $96.9K | $115.8K | $19.3K | $28.1K | $46.6K | $34.8K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Short-term Debt | · | · | · | · | $0 | $820.5K | $586.3K | $419.7K | $516.9K | $69.9K | $102.1K | $480.1K | |
| Current Liabilities | $6M | $6M | $6M | $7M | $91.2K | $1M | $833.5K | $912.5K | $751.1K | $274.1K | $1M | $531.0K | |
| Capital Leases | $596.8K | $744.7K | $539.0K | $642.2K | $0 | · | · | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Total Liabilities | $7M | $7M | $6M | $8M | $2M | $2M | $833.5K | $1M | $830.8K | $274.1K | $1M | $531.0K | |
| Long-term Debt | · | · | · | · | · | $949.0K | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | $820.5K | $586.3K | $419.7K | $516.9K | $69.9K | $305.2K | $480.1K | |
| Common Stock | $4.9K | $2.6K | $14 | $22.6K | $2.6K | $1.7K | $35.3K | $4.3K | $45.9K | $769.4K | $198.3K | $73.6K | |
| Paid-in Capital | $98M | $93M | $84M | $81M | $33M | $19M | $17M | $16M | $13M | $12M | $8M | $7M | |
| Retained Earnings | $-75M | $-69M | $-64M | $-59M | $-33M | $-20M | $-17M | $-16M | $-14M | $-13M | $-9M | $-7M | |
| AOCI | $-65.3K | $-830.0K | $696.1K | $161.8K | $-23.1K | $-2.9K | $-2.5K | $-3.7K | $504 | $394 | $740 | $0 | |
| Stockholders' Equity | $23M | $24M | $21M | $22M | $211.7K | $-954.8K | $-735.4K | $-55.8K | $-573.4K | $-209.7K | $-597.0K | $-387.6K | |
| Liabilities + Equity | $30M | $31M | $27M | $29M | $2M | $1M | $98.1K | $1M | $257.5K | $64.4K | $673.3K | $143.4K | |
| Shares Outstanding | 4,905,945 | 2,580,098 | 14,012 | 22,585,632 | 2,591,240 | 1,732,096 | 35,319,990 | 4,282,620 | 45,936,825 | 769,399,858 | 198,265,118 | 73,551,041 |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $332.1K | $223.5K | $149.1K | $25.2K | $12.7K | $14.1K | $13.8K | $49.4K | $6.6K | $60.7K | $4.3K | $0 | |
| Stock-based Comp | · | · | · | · | · | $271.9K | $277.3K | $755.2K | $520.3K | $499.4K | $116.5K | $1M | |
| Deferred Tax | $94.9K | $-144.5K | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $37.8K | $77.0K | $38.4K | · | $58.9K | $58.9K | $13.8K | $14.4K | $6.6K | $60.7K | $3.8K | $0 | |
| Other Non-cash | $217.3K | $-7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-13M | $-9M | $-5M | $-2M | $-657.3K | $-495.8K | $-512.8K | $-543.5K | $-314.2K | $-867.6K | $-538.6K | |
| CapEx | $174.5K | $2M | $82.3K | $194.0K | $0 | $1.2K | $860 | $18.9K | $3.7K | $3.4K | $4.8K | $0 | |
| Investing Cash Flow | $-836.3K | $-2M | $-656.1K | $-15M | $0 | $-1.2K | $-15.3K | $-13.9K | $-84.0K | $-3.4K | $-623.6K | $0 | |
| Stock Issued | $2M | $9M | $4M | $30M | $0 | · | · | $0 | $63.9K | $104.1K | $236.6K | $153.3K | |
| Stock Repurchased | $0 | $3M | $541.1K | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $2M | $5M | $4M | $30M | · | · | · | $0 | $63.9K | $104.1K | $236.6K | $153.3K | |
| Financing Cash Flow | $5M | $9M | $3M | $39M | $3M | $2M | $442.3K | $527.6K | $670.7K | $324.6K | $1M | $650.8K | |
| Net Change in Cash | · | · | · | · | · | $949.8K | $-68.8K | $926 | $43.2K | $7.0K | $-92.6K | $112.2K | |
| Taxes Paid | $0 | $582.5K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-6M | $-14M | $-9M | $-5M | $-2M | $-658.5K | $-496.7K | $-531.7K | $-547.2K | $-317.6K | $-872.4K | · | |
| Levered FCF | · | · | $-9M | $-5M | · | · | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.8% | 30.6% | 34.6% | 39.0% | 48.4% | 63.8% | 47.7% | 12.6% | · | · | · | · | |
| Operating Margin | -17.2% | -16.7% | -19.9% | -621.3% | -1068.2% | -807.8% | -3037.9% | -260.8% | · | · | -45683.7% | · | |
| Net Margin | -16.5% | -14.7% | -18.7% | -615.4% | -5444.4% | -3898.7% | -7860.9% | -482.2% | · | · | -96774.5% | · | |
| Pretax Margin | -16.4% | -15.4% | -17.1% | -610.1% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -16.2% | -16.0% | -19.9% | -621.3% | -1068.2% | -807.8% | -3037.9% | -260.8% | · | · | -45683.7% | · | |
| ROA | -19.7% | -17.7% | -15.9% | -170.1% | -765.7% | -486.9% | -266.8% | -307.1% | -646.3% | -948.0% | -404.8% | -2214.8% | |
| ROE | -24.5% | -21.1% | -20.9% | -86.3% | 2584.8% | 368.8% | 224.6% | 38884.7% | 265.7% | 866.9% | 335.7% | 978.6% | |
| ROIC | -27.1% | -23.6% | -24.7% | -125.9% | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 4.1 | 4.5 | 3.9 | 24.1 | 1.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | · | |
| Quick Ratio | 0.5 | 0.6 | 0.5 | 3.4 | 22.5 | 0.9 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | · | |
| Debt / Equity | · | · | · | · | 0.0 | -0.9 | -0.8 | -7.5 | -0.9 | -0.3 | -0.5 | -1.2 | |
| Interest Coverage | · | · | -34.9 | -685.1 | -7.4 | -3.4 | -5.5 | -7.3 | -8.2 | -28.6 | -2.5 | -9.8 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 0.9 | 0.3 | 0.1 | 0.1 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 1.9 | 2.8 | 3.5 | 1.6 | 1.8 | · | · | · | · | · | · | · | |
| Receivables Turnover | 9.9 | 10.9 | 10.8 | 4.5 | 47.0 | 60.9 | 98.2 | 9.4 | · | · | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.1% | 44.8% | 454.4% | 1802.4% | 219.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 102.9% | 434.5% | 596.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 247.7% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $36M | $35M | $24M | $4M | $228.4K | $71.4K | $21.1K | $0 | $0 | $0 | $1.7K | $0 | |
| Net Income TTM | $-6M | $-5M | $-5M | $-27M | $-12M | $-3M | $-2M | $-2M | $-1M | $-3M | $-2M | $-2M | |
| Market Cap | $966.5K | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.2 | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | -0.2 | · | · | · | · | · | · | · | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $9M | $9M | $9M | $10M | $8M | $9M | $8M | $8M | $6M | $6M | $5M | $4M | $132.8K | $150.3K | $122.6K | |
| Cost of Revenue | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $5M | $5M | $4M | $4M | $3M | $2M | $65.8K | $74.7K | $59.8K | |
| Gross Profit | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $67.0K | $75.6K | $62.8K | |
| R&D Expense | $73.5K | $119.3K | $196.2K | $215.3K | $149.3K | $126.4K | $436.2K | $222.0K | $816.3K | $238.0K | $368.6K | $432.9K | $41.8K | $362.5K | $45.9K | $361.7K | |
| SG&A Expense | $5M | $4M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $25M | $2M | $771.4K | $1M | |
| Operating Income | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-1M | $-779.5K | $-1M | $-2M | $-23M | $-2M | $-695.8K | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | $49.2K | · | $38.5K | $27.6K | $41.1K | $26.5K | $2 | $0 | $12.9K | |
| Other Non-op | $57.5K | $65.4K | $74.7K | $75.8K | $-200.0K | $123.8K | $430.3K | $89.1K | $133.2K | $168.9K | $199.5K | $172.8K | $84.6K | $261.0K | $156.9K | $-12.9K | |
| Pretax Income | $-2M | $-1M | $-2M | $-1M | $-2M | $-982.6K | $-838.0K | $-1M | $-1M | $-610.5K | $-814.4K | $-2M | $-23M | $-1M | $-538.9K | $-1M | |
| Income Tax | $408.4K | $-137.4K | $-209.2K | $-40.2K | $-128.7K | $215.2K | $-343.7K | $22.4K | $220.3K | $41.0K | $87.7K | $46.3K | $233.3K | $0 | $0 | $0 | |
| Net Income | $-2M | $-883.8K | $-2M | $-1M | $-2M | $-1M | $-494.3K | $-1M | $-1M | $-651.5K | $-902.1K | $-2M | $-24M | $-1M | $-538.9K | $-1M | |
| EPS (Basic) | $-0.42 | $-0.19 | $-0.39 | $-0.44 | $5.56 | $-0.94 | $-9.94 | $-2.00 | $-221.74 | $-50.72 | $-71.17 | $-7.73 | $-1.58 | $0.08 | $-0.03 | $-0.23 | |
| EPS (Diluted) | · | · | $-0.82 | $-0.44 | · | · | $-43.48 | $-2.00 | · | · | · | $-7.73 | · | · | · | $-0.23 | |
| Shares (Basic) | -7,598,260 | 4,555,945 | 4,496,108 | 2,703,293 | -1,256,852 | 1,267,565 | 49,726 | 641,310 | -233,058 | 12,845 | 12,675 | 220,363 | -24,827,138 | 18,885,632 | 15,849,518 | 5,272,856 | |
| Shares (Diluted) | · | · | 3,604,653 | 2,703,293 | · | 1,267,565 | 40,896 | 641,310 | -233,058 | 12,845 | 12,675 | 220,363 | -24,827,138 | 18,885,632 | 15,849,518 | 5,272,856 | |
| EBITDA | · | $-1M | $-2M | $-1M | · | $-1M | $-1M | $-1M | · | $-779.5K | $-989.6K | $-2M | · | $-2M | $-695.8K | $-1M |
Bilanço 22
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | $20M | $19M | · | $41M | $42M | $13M | |
| Receivables | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $22 | $24 | $24 | |
| Inventory | $13M | $14M | $13M | $12M | $11M | $10M | $8M | $8M | $6M | $5M | $4M | $4M | $3M | $269.6K | $205.4K | $181.5K | |
| Prepaid Expense | $798.4K | $441.5K | $939.4K | $983.5K | $1M | $735.8K | $2M | $871.4K | $310.6K | $37.6K | $107.0K | $152.3K | $283.8K | $27.4K | $48.6K | $38.6K | |
| Current Assets | $27M | $28M | $28M | $24M | $26M | $26M | $26M | $29M | $25M | $25M | $26M | $25M | $27M | $41M | $42M | $13M | |
| PP&E (Net) | $557.4K | $598.1K | $638.4K | $519.8K | $546.1K | $590.8K | $541.4K | $401.6K | $365.9K | $334.9K | $366.7K | $368.0K | $394.2K | $3.8K | $1.6K | $4.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $889.0K | $882.6K | · | · | · | $555.9K | · | · | · | $478.1K | · | · | · | |
| Accum. Depreciation | $512.9K | $462.5K | $412.6K | $369.2K | $336.5K | · | · | · | $190.0K | · | · | · | $83.8K | · | $69.2K | $67.3K | |
| Goodwill | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | |
| Intangibles | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $948.2K | $776.9K | · | · | · | |
| Total Assets | $30M | $31M | $32M | $29M | $31M | $30M | $29M | $32M | $27M | $28M | $28M | $27M | $29M | $41M | $42M | $13M | |
| Accounts Payable | $6M | $6M | $5M | $5M | $6M | $4M | $5M | $4M | $3M | $2M | $2M | $3M | $3M | $480.2K | $104.7K | $95.2K | |
| Current Liabilities | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $7M | $6M | $5M | $5M | $7M | $7M | $480.2K | $104.7K | $95.2K | |
| Capital Leases | $596.8K | $636.7K | $706.5K | $722.2K | $744.7K | $440.3K | $462.9K | $497.0K | $539.0K | $555.7K | $596.9K | $613.1K | $642.2K | · | · | · | |
| Total Liabilities | $7M | $7M | $6M | $6M | $7M | $5M | $6M | $7M | $6M | $6M | $5M | $8M | $8M | $480.2K | $104.7K | $95.2K | |
| Common Stock | $4.9K | $4.6K | $4.6K | $2.7K | $2.6K | $2.0K | $1.2K | $995 | $14 | $25.7K | $25.7K | $22.1K | $22.6K | $18.9K | $18.9K | $7.2K | |
| Paid-in Capital | $98M | $97M | $97M | $94M | $93M | $92M | $90M | $90M | $84M | $84M | $84M | $80M | $81M | $76M | $76M | $47M | |
| Retained Earnings | $-75M | $-73M | $-72M | $-70M | $-69M | $-67M | $-66M | $-65M | $-64M | $-63M | $-62M | $-61M | $-59M | $-36M | $-34M | $-34M | |
| AOCI | $-65.3K | $-320.8K | $280.8K | $-803.8K | $-830.0K | $168.6K | $-683.0K | $152.4K | $696.1K | $204.5K | $665.1K | $173.0K | $161.8K | $-79.9K | $-34.8K | $-22.1K | |
| Stockholders' Equity | $23M | $24M | $26M | $23M | $24M | $25M | $23M | $25M | $21M | $22M | $23M | $19M | $22M | $40M | $42M | $13M | |
| Liabilities + Equity | $30M | $31M | $32M | $29M | $31M | $30M | $29M | $32M | $27M | $28M | $28M | $27M | $29M | $41M | $42M | $13M | |
| Shares Outstanding | 4,905,945 | 4,555,945 | 4,555,945 | 2,707,541 | 2,580,098 | 1,999,660 | 1,170,510 | 994,529 | 14,012 | 25,678,290 | 25,746,302 | 22,139,921 | 22,585,632 | 18,885,632 | 18,885,632 | 7,149,778 |
Nakit Akışı 12
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $98.6K | $96.2K | $72.5K | $64.8K | $65.4K | $64.6K | $50.9K | $42.6K | · | $37.2K | $34.9K | $34.7K | $19.0K | $789 | $2.3K | $3.1K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | $11.7K | $10.8K | $8.1K | $7.9K | · | · | · | · | |
| Other Non-cash | · | · | · | $-598.9K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-727.8K | $-1M | $-2M | $-3M | $-1M | $-5M | $-3M | $-3M | $-457.3K | $-4M | $-2M | $-2M | $-1M | $-573.8K | $-1M | |
| CapEx | $-1.0K | $8.0K | $160.0K | $7.5K | $102.6K | $517.0K | $974.5K | $62.9K | $-382.4K | $9.6K | · | · | $194.0K | $0 | · | · | |
| Investing Cash Flow | $-50.2K | $-118.3K | $-491.8K | $-176.0K | $-97.8K | $-670.6K | $-542.2K | $-668.7K | $-269.2K | $18.9K | $-259.5K | $-146.3K | $-15M | $0 | $0 | $0 | |
| Stock Issued | $0 | $0 | $2M | $0 | $0 | $0 | $0 | $9M | $0 | $10 | $4M | $0 | $-13M | $0 | $29M | $14M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | $0 | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $724.5K | $75.5K | $4M | $338.1K | $2M | $2M | $-28.6K | $5M | $-30.5K | $-63.6K | $4M | $-538.3K | $-2M | $0 | $29M | $12M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $-373.5K | $0 | $0 | $956.0K | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Free Cash Flow | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 32.6% | 36.4% | 30.7% | · | 34.0% | 25.3% | 31.2% | · | 33.4% | 35.1% | 37.4% | · | 50.5% | 50.3% | 51.2% | |
| Operating Margin | · | -11.5% | -21.8% | -14.6% | · | -13.1% | -13.6% | -17.9% | · | -13.1% | -17.8% | -37.4% | · | -1293.6% | -462.9% | -997.5% | |
| Net Margin | · | -9.4% | -18.8% | -13.2% | · | -14.2% | -5.3% | -17.0% | · | -10.9% | -16.2% | -34.8% | · | -1097.1% | -358.5% | -1008.0% | |
| Pretax Margin | · | -10.8% | -21.0% | -13.7% | · | -11.7% | -9.0% | -16.7% | · | -10.2% | -14.6% | -33.8% | · | · | · | · | |
| EBITDA Margin | · | -11.5% | -21.8% | -13.8% | · | -13.1% | -13.6% | -17.9% | · | -13.1% | -17.8% | -37.4% | · | -1293.6% | -462.9% | -997.5% | |
| ROA | · | -2.9% | -5.8% | -3.9% | · | -4.2% | -1.7% | -4.4% | · | -1.9% | -2.6% | -8.4% | · | -6.7% | -2.5% | -16.2% | |
| ROE | · | -3.6% | -7.2% | -5.0% | · | -5.1% | -2.1% | -5.8% | · | -2.1% | -2.8% | -10.4% | · | -7.4% | -2.6% | -20.2% | |
| ROIC | · | -3.9% | -7.1% | -5.5% | · | -5.4% | -3.2% | -5.5% | · | -3.8% | -4.7% | -9.7% | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.2 | 5.0 | 4.2 | · | 5.7 | 4.9 | 4.4 | · | 5.0 | 5.6 | 3.6 | · | 85.1 | 401.1 | 140.8 | |
| Quick Ratio | · | 0.6 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.4 | · | 0.4 | 4.7 | 3.1 | · | 84.5 | 398.6 | 138.4 | |
| Interest Coverage | · | · | · | · | · | · | · | -27.5 | · | -20.2 | -35.9 | -44.5 | · | -858990.0 | · | -95.1 |
Verimlilik 3
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | 0.5 | 0.6 | 0.6 | · | 0.8 | 1.1 | 0.9 | · | 1.7 | 1.6 | 1.6 | · | 0.4 | 0.6 | 0.6 | |
| Receivables Turnover | · | 2.6 | 2.5 | 2.8 | · | 3.2 | 3.1 | 3.3 | · | 5.9 | 5.5 | 5.5 | · | 230.8 | 12525.6 | 10220.4 |
Değerleme (TTM) 2
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $36M | $36M | $34M | · | $31M | $28M | $24M | · | $17M | $11M | $5M | · | $456.1K | $376.2K | $266.0K | |
| Net Income TTM | · | $-5M | $-5M | $-4M | · | $-4M | $-3M | $-5M | · | $-5M | $-5M | $-5M | · | $-7M | $-9M | $-14M |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $36M | $35M | $24M | $4M | $228.4K |
| Brüt Kâr Marjı % | 33.8% | 30.6% | 34.6% | 39.0% | 48.4% |
| Faaliyet Kâr Marjı % | -17.2% | -16.7% | -19.9% | -621.3% | -1068.2% |
| Net Gelir | $-6M | $-5M | $-5M | $-27M | $-12M |
| Seyreltilmiş Hisse Başı Kâr | — | $-7.32 | $-351.36 | $-1.76 | $-4.76 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | — | — | 0.0 |
| Cari Oran | 4.2 | 4.1 | 4.5 | 3.9 | 24.1 |
| Cari Oran | 0.5 | 0.6 | 0.5 | 3.4 | 22.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-6M | $-14M | $-9M | $-5M | $-2M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.